Header Logo

Connection

RAJKUMAR VENKATRAMANI to Bevacizumab

Back to Details
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Bevacizumab.
RAJKUMAR VENKATRAMANI
Connection Strength
0.862
Bevacizumab
  1. Systemic bevacizumab for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2020 Nov; 138:110352.
    View in: PubMed
    Score: 0.659
  2. Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab. Pediatr Blood Cancer. 2014 Apr; 61(4):756-9.
    View in: PubMed
    Score: 0.102
  3. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One. 2013; 8(7):e68416.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.